Investor directory

Rimonci Capital

Rimonci Capital is a venture capital firm established in 2016 and based in Beijing, China. The company specializes in cross-border investments between China and Israel, with a particular emphasis on the medical technology and healthcare sectors. Rimonci Capital targets opportunities in vision science, specifically in ophthalmology and optometry, aiming to foster innovation and growth in these fields. Through its strategic investments, the firm seeks to bridge the gap between Chinese and Israeli markets, facilitating the exchange of ideas and technologies in the healthcare domain.
http://www.rimonci.com
https://crunchbase.com/organization/rimonci-capital
https://linkedin.com/company/rimonci-capital
https://pitchbook.com/profiles/investor/178819-39
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=428944732

Richel Liu

Co-Founder and CEO

Past deals in Lyon

Laclarée

Seed Round in 2025
Laclarée Vision specializes in the development of adaptive eyeglasses designed to correct presbyopia. Founded in 2016 and based in Lyon, France, the company utilizes patented fluid technology to create lenses that automatically adjust in real-time to various viewing distances. This innovative approach addresses the needs of individuals aged 45 and older who often find traditional solutions, such as progressive lenses or multiple pairs of glasses, unsatisfactory. By combining adaptive lens technology with refractive correction for conditions like astigmatism, myopia, and hyperopia, Laclarée aims to provide a clearer vision experience for its users.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.